Anti-PACT (PKR activating protein) / PRKRA Antibody [PSH02-15], Unconjugated, Rabbit, Monoclonal

Produktübersicht

• Artikelname: Anti-PACT (PKR activating protein) / PRKRA Antibody [PSH02-15], Unconjugated, Rabbit, Monoclonal
• Artikelnummer: HBO-HA721774
• Hersteller Artikelnummer: HA721774
• Alternativnummer: HBO-HA721774
• Hersteller: HUABIO
• Wirt: Rabbit
• Kategorie: Antikörper
• Applikation: FC, IHC-P, WB
• Spezies Reaktivität: Human, Mouse, Rat
• Immunogen: Recombinant protein within human PACT aa 1-313 (O75569).
• Konjugation: Unconjugated
• Alternative Synonym: DYT16 antibody HSD14 antibody Interferon inducible double stranded RNA dependent protein kinase activator A antibody interferon-inducible double stranded RNA-dependent activator antibody Interferon-inducible double stranded RNA-dependent protein kinase a

Produktbeschreibung

PRKRA can activate EIF2AK2/PKR in the absence of double-stranded RNA (dsRNA), leading to phosphorylation of EIF2S1/EFI2-alpha and inhibition of translation and induction of apoptosis. Required for siRNA production by DICER1 and for subsequent siRNA-media

Produkteigenschaften

• Klonalität: Monoclonal
• Konzentration: 1 mg/mL.
• Klon-Bezeichnung: [PSH02-15]
• Molekulargewicht: Predicted band size: 34 kDa
• UniProt: O75569
• Puffer: PBS (pH7.4), 0.1% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
• Reinheit: Protein A affinity purified.
• Formulierung: Liquid
• Target-Kategorie: PRKRA, PACT, RAX, HSD-14, HSD14
• Antibody Type: Primary Antibody

Anwendungsbeschreibung

• Application Verdünnung: WB: 1:1,000 ,IHC-P: 1:1,000-1:5,000 ,IF-Cell: 1:100 ,IF-Tissue: 1:200 ,FC: 1 µg/mL